MicroRNA signatures in circulating extracellular vesicles shift predictably across the lifespan, offering a quantifiable molecular marker of aging progression. These plasma-derived biomarkers provide a non-invasive window into age-related cellular changes and may enable earlier detection of age-associated disease trajectories.
Key Points
- MicroRNA profiles in blood vesicles change systematically with age
- Plasma-derived extracellular vesicles serve as accessible aging biomarkers
- Age-related RNA signatures may predict disease onset before clinical symptoms
Longevity Analysis
The ability to read aging signatures from circulating extracellular vesicles addresses a fundamental problem in longevity medicine: distinguishing chronological age from biological age and identifying which individuals are aging faster. These microRNA patterns reflect cellular communication and regenerative capacity across tissues, making them valuable for stratifying risk before clinical decline becomes apparent. Practitioners can use such biomarkers to monitor whether interventions actually slow the underlying rate of aging rather than relying solely on symptomatic improvements or crude mortality statistics.
Original published by Nature - npj Aging, by C. Ráez-Meseguer.